Quick Answer
ABEONA THERAPEUTICS INC. reported Stockholders Equity of $159.22 million for fiscal year 2025.
ABEONA THERAPEUTICS INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $159.22M | +261.6% |
| 2024 | $44.03M | +197.0% |
| 2023 | $14.83M | -44.6% |
| 2022 | $26.76M | -36.8% |
| 2021 | $42.37M | -58.7% |
| 2020 | $102.55M | -42.5% |
| 2019 | $178.43M | +33.1% |
| 2018 | $134.04M | -21.2% |
| 2017 | $170.10M | +71.6% |
| 2016 | $99.10M | +46.3% |
| 2015 | $67.72M | +1306.2% |
| 2014 | $4.82M | +132.6% |
| 2013 | -$14.78M | +13.5% |
| 2012 | -$17.08M | +3.0% |
| 2011 | -$17.61M | +15.3% |
| 2010 | -$20.80M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $171.23M | +274.1% | +4.7% |
| June 30, 2025 | $163.58M | +123.3% | +295.1% |
| March 31, 2025 | $41.40M | +566.1% | -6.0% |
| December 31, 2024 | $44.03M | +197.0% | -3.8% |
| September 30, 2024 | $45.77M | +107.7% | -37.5% |
| June 30, 2024 | $73.24M | +683.7% | +924.7% |
| March 31, 2024 | -$8.88M | -147.4% | -159.9% |
| December 31, 2023 | $14.83M | -44.6% | -32.7% |
- ABEONA THERAPEUTICS INC. showed an increase of +261.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, ABEONA THERAPEUTICS INC.’s stockholders equity has grown by 865.6% (from -$20.80 million to $159.22 million).
- The most recent figure is from ABEONA THERAPEUTICS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: